Information  X 
Enter a valid email address

Verseon Corporation (VERS)

  Print      Mail a friend

Tuesday 29 October, 2019

Verseon Corporation

Result of 2019 AGM

RNS Number : 4392R
Verseon Corporation
29 October 2019

                                                                                                                                                            October 29, 2019


Verseon Corporation

("Verseon" or the "Company")

Result of 2019 AGM

Fremont, Calif.-Verseon Corporation (AIM: VERS), a clinical-stage pharmaceutical company, announces that all resolutions put to shareholders during the Annual General Meeting ("AGM") held on October 28, 2019 at 9:00 am PDT were duly passed.


For further information, please contact

Verseon Corporation

Sebastian Wykeham / Tina Schlafly

+1 (510) 225 9000



Arden Partners (NOMAD and Broker)


Ruari McGirr / Ciaran Walsh / Dan Gee-Summons (Corporate Finance) / Fraser Marshall (Equity Sales)

 +44 (0) 20 7614 5900


For trade and pharma media enquiries, please contact

Vane Percy & Roberts


Simon Vane Percy

+44 (0) 1737 821 890



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t